Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
Diphtheria
MeSH D004165 - diphtheria
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D003354:
Corynebacterium infections
0 Companies
0 Drugs
Success rate
D004165:
Â
Diphtheria
22 Companies
4 Drugs
$
Success rate
Events Timeline
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
100
%
1/1
Phase 3
100
%
8/8
Approved:
3
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
GSK
Penicillin v
,
Ademetionine
,
Sodium chloride
,
Sodium lactate
,
Microcrystalline cellulose
,
Edetic acid
,
Synflorix
,
Fendrix
,
Fluzone
,
Prevenar13
,
Prevnar13
,
Prp
,
Menactra
,
Pneumovax
,
Ipv
,
Repevax
,
Flumist
,
Flucelvax
,
Prevenar
,
Evidence
Sanofi
Ademetionine
,
Sodium chloride
,
Aspartame
,
Bevifimod
,
Recombivax
,
Fendrix
,
Fluzone
,
Pdt
,
Prevenar13
,
Prevnar13
,
Prp
,
Menactra
,
Pcv13
,
Pneumovax
,
Triapine
,
Vaxigrip
,
Ipv
,
Repevax
,
Flumist
,
Pcv
,
Flucelvax
,
Prevenar
Pfizer
Penicillin g
,
Penicillin g benzathine
,
Penicillin g procaine
,
Penicillin v
1
2
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use